Nuvaira, Inc.

6500 Wedgwood Rd N Ste 100, Maple Grove, Minnesota, United States

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

57.1%

Phase 1

28.6%

Trial Status Distribution

Active, not recruiting

14.3%

Completed

42.9%

Recruiting

14.3%

Terminated

14.3%

Withdrawn

14.3%

Clinical Trials

Trials sponsored by this organization (7)

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

Not Applicable

Recruiting

interventional

Feb 2026200 participants

Evaluation of the Safety and Efficacy of TLD in Patients with COPD

Not Applicable

Active, not recruiting

interventional

May 2019464 participants

Evaluating the Safety and Feasibility of TLD for the Treatment of Severe Asthma

Not Applicable

Terminated

interventional

Dec 20172 participants

Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population

Withdrawn

observational

Dec 2017

Approvals

No approval data available

News

No news articles found

Back to Organizations

Nuvaira, Inc.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (7)

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

Evaluation of the Safety and Efficacy of TLD in Patients with COPD

Evaluating the Safety and Feasibility of TLD for the Treatment of Severe Asthma

Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population

Targeted Lung Denervation for Patients With Moderate to Severe COPD

Evaluation of the IPS System for TLD Therapy in Patients With COPD

Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation

Approvals

News